Nina Horowitz
Company: ImmuneBridge
Job title: Chief Scientific Officer
Seminars:
Chair’s Opening Remarks 8:50 am
day: Conference Day Two
Roundtable Discussion: Enhancing Allogeneic Cell Therapy Success by Optimizing Donor Selection Early in Development 10:00 am
Exploring how early collaboration between R&D and manufacturing enhances donor selection and long-term success Understanding which donor characterization methods drive consistency, efficiency, and clinical readiness Reducing downstream risks by integrating strategic donor profiling early in development timelinesRead more
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day One
Maximizing Process Yield Through Understanding Donor Variability 11:45 am
Gaining tools to better predict process yield from donor characteristics Reducing manufacturing bottlenecks by smoothing production flow Proving product consistency to change investor sentiment about variability Read more
day: Conference Day One